medical waste treatment
Scope
Date
~
-
Culture & Trends
S.Korea’s medical tourism thrives on weak currency
Foreign visitors to South Korea jumped nearly 20% early this year, largely driven by a sharp depreciation in the country’s currency value agai...
Apr 18, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem’s medical skincare business sale draws tepid bid
South Korean chemical giant LG Chem Ltd.'s offer for sale of its cosmetics filler business, tagged with an asking price of more than 500 billion won...
Apr 18, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Corporate restructuring
SK Ecoplant seeks to sell waste treatment business for $1.4 billion
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...
Feb 12, 2025 (Gmt+09:00)
-
Medical devices
Middle East: New land of opportunity for Korean medical devices
South Korea is making inroads into the Middle East's medical device market dominated by the US and Europe, aiming to leverage the region’s str...
Feb 10, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem embarks on sale of dermal filler business worth $343 million
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Feb 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Feb 05, 2025 (Gmt+09:00)
-
Bio & Pharma
Partners Investment, GordonMD eye $150 mn biotech fund launch
South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...
Jan 23, 2025 (Gmt+09:00)
-
Robotics
Koh Young gets OK from FDA for brain surgery robot
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...
Jan 21, 2025 (Gmt+09:00)
-
Batteries
SK Ecoplant, BMW team up for battery recycling
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, partnered with German luxury carmaker BMW to...
Jan 14, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Glenwood buys three waste management firms for about $190 mn
Glenwood Private Equity on Tuesday signed an agreement to buy three waste management companies from small South Korean business group Bubang for aro...
Nov 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca
Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...
Nov 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
-
Electronics
LG Electronics to venture into food waste disposer market
LG Electronics Inc., the world's largest home appliance maker, will foray into the food waste disposer market in the first quarter of 2025, heraldin...
Nov 04, 2024 (Gmt+09:00)
-
Bio & Pharma
PharmaResearch hosts 5th global symposium on 'Rejuran'
PharmaResearch Co. announced that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on Oct. ...
Nov 04, 2024 (Gmt+09:00)
-
Chemical Industry
HD Hyundai OCI supplies recycled tire materials to Hankook Tire
HD Hyundai OCI, the petrochemical affiliate of HD Hyundai Oilbank, said on Tuesday it started to supply Hankook Tire & Technology with recycled ...
Oct 29, 2024 (Gmt+09:00)
-
Energy
DS Dansuk wins $750 mn SAF material order from Phillips 66
South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...
Oct 29, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
-
Automobiles
Kia unveils car accessory made from ocean plastic waste
Kia Corp., South Korea’s second-largest automaker, said on Tuesday it introduced a trunk liner (mat) for the EV3, made from ocean plastic wast...
Oct 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Osstem Implant to boost digital dentistry business
South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...
Sep 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Aug 30, 2024 (Gmt+09:00)
-
Bio & Pharma
CHA Healthcare incorporates Singapore's SMG as subsidiary
South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare an...
Aug 19, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
GS E&C in talks to sell entire stake in GS Elevator to Chinese firm
South Korea’s GS Engineering & Construction Corp. (GS E&C) is in talks to sell its entire stake in GS Elevator Co. to a Chinese strate...
Aug 14, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand